The Unexplained Female Predominance of Systemic Lupus Erythematosus: Clues from Genetic and Cytokine Studies
- 10 January 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Reviews in Allergy & Immunology
- Vol. 40 (1), 42-49
- https://doi.org/10.1007/s12016-009-8192-4
Abstract
Despite recent progress in the understanding of systemic lupus erythematosus (SLE), the striking 9:1 female to male ratio of disease incidence remains largely unexplained. In addition, peak SLE incidence rates occur during the early reproductive years in women. Studies which illuminate potential causes underlying this sex difference and characteristic onset during the reproductive years have the potential to fundamentally advance our understanding of disease pathogenesis in SLE. Similarly, progress in this area will likely inform human reproductive immunology. Studies of sex hormone function in the immune system are of obvious importance; however, it seems likely that many other types of sex-related genetic and immunological differences will contribute to SLE. In this review, we will focus on recent work in sex-related differences in cytokine pathways and genetics of these pathways as they relate to SLE pathogenesis. It seems quite possible that many of these sex-related differences could be important to reproductive fitness, which may explain the conservation of these immune system features and the observed female predominance of SLE.Keywords
This publication has 73 references indexed in Scilit:
- Genetic regulation of serum cytokines in systemic lupus erythematosusTranslational Research, 2010
- Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon‐α activity in lupus patientsArthritis & Rheumatism, 2010
- Elevated serum interferon‐α activity in juvenile dermatomyositis: Associations with disease activity at diagnosis and after thirty‐six months of therapyArthritis & Rheumatism, 2009
- The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon‐α activity and low tumor necrosis factor α levels in patients with lupusArthritis & Rheumatism, 2008
- Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: Support for the notion of a gene‐dose effect from the X chromosomeArthritis & Rheumatism, 2008
- Association of the IRF5 risk haplotype with high serum interferon‐α activity in systemic lupus erythematosus patientsArthritis & Rheumatism, 2008
- Age‐ and sex‐related patterns of serum interferon‐α activity in lupus familiesArthritis & Rheumatism, 2008
- Serum type I interferon activity is dependent on maternal diagnosis in anti‐SSA/Ro–positive mothers of children with neonatal lupusArthritis & Rheumatism, 2008
- Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositisArthritis & Rheumatism, 2007
- Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization dataArthritis & Rheumatism, 2007